Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal WomenPernille Ravn, Claus Christiansen, A.J.P. Yates et al.|Journal of Bone and Mineral Research|1999Cited by 455
The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosisKristine E. Ensrud, B. Mitlak, D Black et al.|ORBi (University of Liège)|1998Cited by 21
Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal womenPD Delmas, H K Genant, KE Ensrud et al.|ORBi (University of Liège)|1999Cited by 4
NEW AGENT FOR THE PREVENTION OF OSTEOPOROSIS, AND CARDIOVASCULAR DISEASE IN POSTMENOPAUSAL WOMENPD Delmas, B. Mitlak, N. H. Bjarnason|Southern Medical Journal|1998Cited by 0